Capital Impact Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$38.75 - $86.92 $6.01 Million - $13.5 Million
-155,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$34.61 - $123.66 $1.56 Million - $5.56 Million
45,000 Added 40.91%
155,000 $6.72 Million
Q3 2020

Nov 13, 2020
BUY
$37.49 - $63.19 $4.12 Million - $6.95 Million
110,000 New
110,000 $4.72 Million

Others Institutions Holding ARCT

# of Institutions
180
Shares Held
25.7M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $432M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email